236 related articles for article (PubMed ID: 22652704)
1. Natriuretic peptide receptor guanylyl cyclase-A protects podocytes from aldosterone-induced glomerular injury.
Ogawa Y; Mukoyama M; Yokoi H; Kasahara M; Mori K; Kato Y; Kuwabara T; Imamaki H; Kawanishi T; Koga K; Ishii A; Tokudome T; Kishimoto I; Sugawara A; Nakao K
J Am Soc Nephrol; 2012 Jul; 23(7):1198-209. PubMed ID: 22652704
[TBL] [Abstract][Full Text] [Related]
2. Natriuretic peptide receptor guanylyl cyclase-A pathway counteracts glomerular injury evoked by aldosterone through p38 mitogen-activated protein kinase inhibition.
Kato Y; Mori K; Kasahara M; Osaki K; Ishii A; Mori KP; Toda N; Ohno S; Kuwabara T; Tokudome T; Kishimoto I; Saleem MA; Matsusaka T; Nakao K; Mukoyama M; Yanagita M; Yokoi H
Sci Rep; 2017 Apr; 7():46624. PubMed ID: 28429785
[TBL] [Abstract][Full Text] [Related]
3. Dual deletion of guanylyl cyclase-A and p38 mitogen-activated protein kinase in podocytes with aldosterone administration causes glomerular intra-capillary thrombi.
Sugioka S; Yamada H; Ishii A; Kato Y; Yamada R; Mori KP; Ohno S; Handa T; Ikushima A; Ishimura T; Osaki K; Tokudome T; Matsusaka T; Nebreda AR; Yanagita M; Yokoi H
Kidney Int; 2023 Sep; 104(3):508-525. PubMed ID: 37356621
[TBL] [Abstract][Full Text] [Related]
4. Podocyte as the target for aldosterone: roles of oxidative stress and Sgk1.
Shibata S; Nagase M; Yoshida S; Kawachi H; Fujita T
Hypertension; 2007 Feb; 49(2):355-64. PubMed ID: 17200434
[TBL] [Abstract][Full Text] [Related]
5. Natriuretic Peptide Receptor Guanylyl Cyclase-A in Podocytes is Renoprotective but Dispensable for Physiologic Renal Function.
Staffel J; Valletta D; Federlein A; Ehm K; Volkmann R; Füchsl AM; Witzgall R; Kuhn M; Schweda F
J Am Soc Nephrol; 2017 Jan; 28(1):260-277. PubMed ID: 27153922
[TBL] [Abstract][Full Text] [Related]
6. Natriuretic peptides buffer renin-dependent hypertension.
Demerath T; Staffel J; Schreiber A; Valletta D; Schweda F
Am J Physiol Renal Physiol; 2014 Jun; 306(12):F1489-98. PubMed ID: 24717731
[TBL] [Abstract][Full Text] [Related]
7. Aggravated renal tubular damage and interstitial fibrosis in mice lacking guanylyl cyclase-A (GC-A), a receptor for atrial and B-type natriuretic peptides.
Yoshihara F; Tokudome T; Kishimoto I; Otani K; Kuwabara A; Horio T; Kawano Y; Kangawa K
Clin Exp Nephrol; 2015 Apr; 19(2):197-207. PubMed ID: 24845230
[TBL] [Abstract][Full Text] [Related]
8. Role of natriuretic peptide receptor guanylyl cyclase-A in myocardial infarction evaluated using genetically engineered mice.
Nakanishi M; Saito Y; Kishimoto I; Harada M; Kuwahara K; Takahashi N; Kawakami R; Nakagawa Y; Tanimoto K; Yasuno S; Usami S; Li Y; Adachi Y; Fukamizu A; Garbers DL; Nakao K
Hypertension; 2005 Aug; 46(2):441-7. PubMed ID: 15998711
[TBL] [Abstract][Full Text] [Related]
9. Osteocrin ameliorates adriamycin nephropathy via p38 mitogen-activated protein kinase inhibition.
Handa T; Mori KP; Ishii A; Ohno S; Kanai Y; Watanabe-Takano H; Yasoda A; Kuwabara T; Takahashi N; Mochizuki N; Mukoyama M; Yanagita M; Yokoi H
Sci Rep; 2021 Nov; 11(1):21835. PubMed ID: 34750411
[TBL] [Abstract][Full Text] [Related]
10. Genetic disruption of guanylyl cyclase/natriuretic peptide receptor-A upregulates ACE and AT1 receptor gene expression and signaling: role in cardiac hypertrophy.
Vellaichamy E; Zhao D; Somanna N; Pandey KN
Physiol Genomics; 2007 Oct; 31(2):193-202. PubMed ID: 17566078
[TBL] [Abstract][Full Text] [Related]
11. Podocyte injury underlies the glomerulopathy of Dahl salt-hypertensive rats and is reversed by aldosterone blocker.
Nagase M; Shibata S; Yoshida S; Nagase T; Gotoda T; Fujita T
Hypertension; 2006 Jun; 47(6):1084-93. PubMed ID: 16636193
[TBL] [Abstract][Full Text] [Related]
12. Oxidative stress-induced glomerular mineralocorticoid receptor activation limits the benefit of salt reduction in Dahl salt-sensitive rats.
Kitada K; Nakano D; Liu Y; Fujisawa Y; Hitomi H; Shibayama Y; Shibata H; Nagai Y; Mori H; Masaki T; Kobori H; Nishiyama A
PLoS One; 2012; 7(7):e41896. PubMed ID: 22911865
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of brain natriuretic peptide in mice ameliorates immune-mediated renal injury.
Suganami T; Mukoyama M; Sugawara A; Mori K; Nagae T; Kasahara M; Yahata K; Makino H; Fujinaga Y; Ogawa Y; Tanaka I; Nakao K
J Am Soc Nephrol; 2001 Dec; 12(12):2652-2663. PubMed ID: 11729234
[TBL] [Abstract][Full Text] [Related]
14. Salt accelerates aldosterone-induced cardiac remodeling in the absence of guanylyl cyclase-A signaling.
Nakagawa H; Somekawa S; Onoue K; Kumazawa T; Ueda T; Seno A; Nakada Y; Nakano T; Matsui M; Soeda T; Okayama S; Kawakami R; Kawata H; Okura H; Saito Y
Life Sci; 2016 Nov; 165():9-15. PubMed ID: 27647418
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin receptor blocker protection against podocyte-induced sclerosis is podocyte angiotensin II type 1 receptor-independent.
Matsusaka T; Asano T; Niimura F; Kinomura M; Shimizu A; Shintani A; Pastan I; Fogo AB; Ichikawa I
Hypertension; 2010 Apr; 55(4):967-73. PubMed ID: 20142565
[TBL] [Abstract][Full Text] [Related]
16. Increased susceptibility to heart failure in response to volume overload in mice lacking natriuretic peptide receptor-A gene.
Nishikimi T; Hagaman JR; Takahashi N; Kim HS; Matsuoka H; Smithies O; Maeda N
Cardiovasc Res; 2005 Apr; 66(1):94-103. PubMed ID: 15769452
[TBL] [Abstract][Full Text] [Related]
17. Guanylyl cyclase/natriuretic peptide receptor-A gene disruption causes increased adrenal angiotensin II and aldosterone levels.
Zhao D; Vellaichamy E; Somanna NK; Pandey KN
Am J Physiol Renal Physiol; 2007 Jul; 293(1):F121-7. PubMed ID: 17389676
[TBL] [Abstract][Full Text] [Related]
18. Genetic disruption of guanylyl cyclase/natriuretic peptide receptor-A upregulates renal (pro) renin receptor expression in Npr1 null mutant mice.
Periyasamy R; Das S; Pandey KN
Peptides; 2019 Apr; 114():17-28. PubMed ID: 30965084
[TBL] [Abstract][Full Text] [Related]
19. Blockade of the natriuretic peptide clearance receptor attenuates proteinuria in a mouse model of focal segmental glomerulosclerosis.
Wang L; Tang Y; Buckley AF; Spurney RF
Physiol Rep; 2021 Nov; 9(21):e15095. PubMed ID: 34755480
[TBL] [Abstract][Full Text] [Related]
20. Guanylyl cyclase-A inhibits angiotensin II type 1A receptor-mediated cardiac remodeling, an endogenous protective mechanism in the heart.
Li Y; Kishimoto I; Saito Y; Harada M; Kuwahara K; Izumi T; Takahashi N; Kawakami R; Tanimoto K; Nakagawa Y; Nakanishi M; Adachi Y; Garbers DL; Fukamizu A; Nakao K
Circulation; 2002 Sep; 106(13):1722-8. PubMed ID: 12270869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
